1.
Establishment of a novel safety assessment method for vaccine adjuvant development
by Sasaki, Eita
Vaccine, 2018-11-12, Vol.36 (46), p.7112-7118
2.
Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan
by Momose, Haruka
Vaccine, 2018-10-15, Vol.36 (43), p.6449-6455
3.
A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests
by Sasaki, Eita
Vaccine, 2016, Vol.35 (5), p.821-830
4.
5.
Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation
by Mizukami, Takuo
Vaccine, 2008, Vol.26 (18), p.2270-2283
6.
Application of quantitative gene expression analysis for pertussis vaccine safety control
by Hamaguchi, Isao
Vaccine, 2008, Vol.26 (36), p.4686-4696
7.
Two vaccine toxicity-related genes Agp and Hpx could prove useful for pertussis vaccine safety control
by Hamaguchi, Isao
Vaccine, 2007, Vol.25 (17), p.3355-3364
8.
A New Method for the Evaluation of Vaccine Safety Based on Comprehensive Gene Expression Analysis
by Momose, Haruka
Journal of biomedicine & biotechnology, 2010-05-12, Vol.2010, p.361841-7
